Professional Marketing briefs: April 2012

Professional Marketing briefs: April 2012
Professional Marketing briefs: April 2012
GlaxoSmithKline and Daiichi ­Sankyo announced they will  team up to create Japan's largest vaccine company. The joint effort will be a 50-50 partnership, with an initial investment of at least ¥100,000,000 ($1.2 million) in seed money, according to a GSK statement. The two companies will distribute vaccines for HPV, rotavirus and measles rubella, among others.

Columbia Laboratories is reducing its headcount by 10, leaving it with 14 employees. The announcement follows the FDA's rejection of the company's progesterone vaginal 8% gel, intended to reduce the risk of pre-term birth. An approval would have meant a $30 million commercial launch payment from Watson Pharmaceuticals, which has the rights to the gel.

Eli Lilly announced the opening of offices with 200 research and manufacturing jobs to fill at its Kinsale campus in County Cork, Ireland (above). The jobs are part of the company's €330 million ($435 million) investment in a campus currently dedicated to small-molecule manufacturing. The investment will expand the site's footprint so that it could be the launch pad for the pharmaceutical company's biologics pipeline.
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Pharma continues to struggle with its image. Exhibit A is the public debate around the price of, and access to, new and innovative meds. As countless transformative technologies hit market, has industry done enough to anchor its permission to innovate? To provide a closer look at trends affecting trust over the past year, MM&M presents this e-book, "The 2015 Edelman Trust Barometer." Click here.

Email Newsletters